[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/15, THU) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 로슈 "비만 의지", 中서 'ALK7 RNAi' 11.6억弗 사들여
[https://www.biospectator.com/news/view/30071](https://www.biospectator.com/news/view/30071)

 화이자, 에노디아와 ‘수송체 저해제’ 저분자 5억弗 딜
[https://www.biospectator.com/news/view/30079](https://www.biospectator.com/news/view/30079)

 셀트리온, 유럽 UEG Week 단독부스 "램시마SC 소개"
[https://www.biospectator.com/news/view/30092](https://www.biospectator.com/news/view/30092)

 히츠, 시리즈B 183억 유치..'AI 연구 플랫폼 고도화"
[https://www.biospectator.com/news/view/30090](https://www.biospectator.com/news/view/30090)

 베르티스, '표면단백질 타깃발굴' 스케일업 팁스 선정 
[https://www.biospectator.com/news/view/30093](https://www.biospectator.com/news/view/30093)

 질랜드, 제너레이트와 비만 ‘다중단백질’ 발굴 12억弗 딜
[https://www.biospectator.com/news/view/30080](https://www.biospectator.com/news/view/30080)

 리가켐, World ADC Awards ‘최고 ADC 플랫폼’ 수상 
[https://www.biospectator.com/news/view/30097](https://www.biospectator.com/news/view/30097)

 애로우헤드, '타우 siRNA' AD 1/2a상 "타우 73% 감소"
[https://www.biospectator.com/news/view/30089](https://www.biospectator.com/news/view/30089)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/15, THU) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)